Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Abstract B9: Is delayed diagnosis of lung cancer preventable?

View through CrossRef
Abstract Background: Major efforts have been made worldwide to speed the process of referral for patients with suspected lung cancer. Delay in diagnosis of cancer is recognized as an important factor in the overall outcome of treatment. Aim: The purpose of this study was to test if the symptom history of patients with operable disease differs from that of patients with inoperable disease. Methods: 39 men and women recently diagnosed with lung cancer at Assiut University Hospital during the period from August 2009-June 2010 were included in this study. The main outcome measures were the symptoms leading up to a diagnosis of lung cancer in operable and inoperable cases. Results: Patients recalled having new symptoms for many months, typically over the year before their diagnosis, irrespective of their disease stage once diagnosed. In the time interval between appearance of the first symptom and operation, a significantly shorter median delay was found for patients with operable and inoperable lung cancer (P=0.028). Concerning the interval from first contact with the healthcare system to operation a significantly shorter median delay was found for the group of patients in operable compared to the inoperable patients (P=0.019). Conclusion: Our findings, although preliminary, suggest that the widely held view that lung cancer is silent until far advanced may be inaccurate. Encouragement to present early with signs of lung cancer should be considered alongside other efforts to speed up diagnosis and treatment. A few months delay before final treatment of a non-small-cell lung cancer seems to have an impact on the perioperative stage of the cancer, and thereby on the patients prognosis. A screening of asymptomatic risk-group patients will result in recognition of early lung cancer. Citation Information: Cancer Prev Res 2010;3(12 Suppl):B9.
American Association for Cancer Research (AACR)
Title: Abstract B9: Is delayed diagnosis of lung cancer preventable?
Description:
Abstract Background: Major efforts have been made worldwide to speed the process of referral for patients with suspected lung cancer.
Delay in diagnosis of cancer is recognized as an important factor in the overall outcome of treatment.
Aim: The purpose of this study was to test if the symptom history of patients with operable disease differs from that of patients with inoperable disease.
Methods: 39 men and women recently diagnosed with lung cancer at Assiut University Hospital during the period from August 2009-June 2010 were included in this study.
The main outcome measures were the symptoms leading up to a diagnosis of lung cancer in operable and inoperable cases.
Results: Patients recalled having new symptoms for many months, typically over the year before their diagnosis, irrespective of their disease stage once diagnosed.
In the time interval between appearance of the first symptom and operation, a significantly shorter median delay was found for patients with operable and inoperable lung cancer (P=0.
028).
Concerning the interval from first contact with the healthcare system to operation a significantly shorter median delay was found for the group of patients in operable compared to the inoperable patients (P=0.
019).
Conclusion: Our findings, although preliminary, suggest that the widely held view that lung cancer is silent until far advanced may be inaccurate.
Encouragement to present early with signs of lung cancer should be considered alongside other efforts to speed up diagnosis and treatment.
A few months delay before final treatment of a non-small-cell lung cancer seems to have an impact on the perioperative stage of the cancer, and thereby on the patients prognosis.
A screening of asymptomatic risk-group patients will result in recognition of early lung cancer.
Citation Information: Cancer Prev Res 2010;3(12 Suppl):B9.

Related Results

Abstract SY38-02: Clinical investigations of obesity in cancer: BMI and other confounders
Abstract SY38-02: Clinical investigations of obesity in cancer: BMI and other confounders
Abstract Obesity has been linked with increased incidence and worse outcomes of at least 13 human cancers. For other cancers, our understanding of their relationship...
Abstract 1345: Evidence for genetic mediation of lung cancer through hay fever.
Abstract 1345: Evidence for genetic mediation of lung cancer through hay fever.
Abstract Introduction: In the past decade, advances in genetics have led to the discovery of numerous lung cancer susceptibility variants. The majority of these vari...
Time to Start Up: CT-Basted Radiomics in Children’s Lung Diseases
Time to Start Up: CT-Basted Radiomics in Children’s Lung Diseases
Radiomics is a new interdisciplinary field and a fusion product consisting by large data technology and medical image to aid diagnosis. Radiomics can gather information from differ...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract Introduction Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
RNA Demethylase ALKBH5 Promotes Progression and Angiogenesis of Lung Cancer via Regulating the Stability of LncRNA PVT1
RNA Demethylase ALKBH5 Promotes Progression and Angiogenesis of Lung Cancer via Regulating the Stability of LncRNA PVT1
Abstract Background N6-methyladenosine (m6A) is the most common posttranscriptional modification of RNA and plays critical roles in human cancer progression. However, biol...
Abstract LB-243: Precision medicine: Lung biomarkers
Abstract LB-243: Precision medicine: Lung biomarkers
Abstract More than half of all new lung cancer diagnoses are made in patients with locally advanced or metastatic disease, at which point therapeutic options are sca...

Back to Top